Collectively these data highlight that FATE1 plays a key role in the aggressive phenotype of adrenocortical carcinoma and is also implicated in the resistance to chemotherapeutic treatments in other kinds of cancer. This evidence concerns the gene FATE1 and adrenal cortex carcinoma.